These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 19154482)

  • 41. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
    Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
    Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic value of the serum galactomannan assay for invasive aspergillosis: it is less useful in non-haematological patients.
    Ku NS; Han SH; Choi JY; Kim SB; Kim HW; Jeong SJ; Kim CO; Song YG; Kim JM
    Scand J Infect Dis; 2012 Aug; 44(8):600-4. PubMed ID: 22385270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
    J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assay.
    Morio F; Fraissinet F; Gastinne T; Le Pape P; Delaunay J; Sigler L; Gibas CF; Miegeville M
    Med Mycol; 2011 Nov; 49(8):883-6. PubMed ID: 21619496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The value of serum galactomannan detection for diagnosis of invasive aspergillosis in hematopoietic stem cell transplant recipients].
    Ji Y; Liu DH; Xu LP; Liu KY; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):83-6. PubMed ID: 17650666
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies.
    Florent M; Katsahian S; Vekhoff A; Levy V; Rio B; Marie JP; Bouvet A; Cornet M
    J Infect Dis; 2006 Mar; 193(5):741-7. PubMed ID: 16453271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients.
    Steinbach WJ; Addison RM; McLaughlin L; Gerrald Q; Martin PL; Driscoll T; Bentsen C; Perfect JR; Alexander BD
    Pediatr Infect Dis J; 2007 Jul; 26(7):558-64. PubMed ID: 17596794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The retrospective study of serum aspergillus galactomannan (GM) antigen assay in invasive aspergillosis on hematological diseases].
    Wang YY; Xiao CL; Li JM; Zhao WL; Mi JQ; Hu J; Ni YX; Shen ZX
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):498-501. PubMed ID: 23827105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The significance of serum GM and BG antigens assay for invasive fungal infections in hematological malignancies patients].
    Zeng SY; Liu T; Meng WT; Chen YN
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):43-6. PubMed ID: 21429401
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies.
    Rogers TR; Morton CO; Springer J; Conneally E; Heinz W; Kenny C; Frost S; Einsele H; Loeffler J
    Br J Haematol; 2013 May; 161(4):517-24. PubMed ID: 23614624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients.
    Maertens J; Van Eldere J; Verhaegen J; Verbeken E; Verschakelen J; Boogaerts M
    J Infect Dis; 2002 Nov; 186(9):1297-306. PubMed ID: 12402199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey.
    Cornillet A; Camus C; Nimubona S; Gandemer V; Tattevin P; Belleguic C; Chevrier S; Meunier C; Lebert C; Aupée M; Caulet-Maugendre S; Faucheux M; Lelong B; Leray E; Guiguen C; Gangneux JP
    Clin Infect Dis; 2006 Sep; 43(5):577-84. PubMed ID: 16886149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The misleading effect of serum galactomannan testing in high-risk haematology patients receiving prophylaxis with micafungin.
    Vena A; Bouza E; Álvarez-Uría A; Gayoso J; Martín-Rabadán P; Cajuste F; Guinea J; Gómez Castellá J; Alonso R; Munoz P
    Clin Microbiol Infect; 2017 Dec; 23(12):1000.e1-1000.e4. PubMed ID: 28506782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia.
    Halliday C; Hoile R; Sorrell T; James G; Yadav S; Shaw P; Bleakley M; Bradstock K; Chen S
    Br J Haematol; 2006 Feb; 132(4):478-86. PubMed ID: 16412020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: Single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes.
    Parody R; Martino R; Sánchez F; Subirá M; Hidalgo A; Sierra J
    Am J Hematol; 2009 Sep; 84(9):571-8. PubMed ID: 19676118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies.
    Ulusakarya A; Chachaty E; Vantelon JM; Youssef A; Tancrède C; Pico JL; Bourhis JH; Fenaux P; Munck JN
    Hematol J; 2000; 1(2):111-6. PubMed ID: 11920178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum galactomannan strongly correlates with outcome of invasive aspergillosis in acute leukaemia patients.
    Park SH; Choi SM; Lee DG; Choi JH; Kim SH; Kwon JC; Yoo JH; Kim HJ; Lee S; Eom KS; Min WS
    Mycoses; 2011 Nov; 54(6):523-30. PubMed ID: 21605195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patients.
    Couchepin J; Brunel AS; Jaton K; Meylan P; Bochud PY; Lamoth F
    Mycoses; 2018 Jun; 61(6):350-354. PubMed ID: 29453853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Threshold of galactomannan antigenemia positivity for early diagnosis of invasive aspergillosis in neutropenic children.
    Dinand V; Anjan M; Oberoi JK; Khanna S; Yadav SP; Wattal C; Sachdeva A
    J Microbiol Immunol Infect; 2016 Feb; 49(1):66-73. PubMed ID: 24582464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy.
    Hoenigl M; Seeber K; Koidl C; Buzina W; Wölfler A; Duettmann W; Wagner J; Strenger V; Krause R
    Mycoses; 2013 Jul; 56(4):471-6. PubMed ID: 23432536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.